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Bennett J. Waxse1,2, Prabuddha Sengupta1, Geoffrey G. Hesketh3, Jennifer Lippincott-Schwartz1,* and
Folma Buss2,*
ABSTRACT
In this study, we demonstrate myosin VI enrichment at Cx43 (also
known as GJA1)-containing gap junctions (GJs) in heart tissue,
primary cardiomyocytes and cell culture models. In primary cardiac
tissue and in fibroblasts from the myosin VI-null mouse as well as in
tissue culture cells transfected with siRNA against myosin VI, we
observe reduced GJ plaque size with a concomitant reduction in
intercellular communication, as shown by fluorescence recovery after
photobleaching (FRAP) and a new method of selective calcein
administration. Analysis of the molecular role of myosin VI in Cx43
trafficking indicates that myosin VI is dispensable for the delivery of
Cx43 to the cell surface and connexon movement in the plasma
membrane. Furthermore, we cannot corroborate clathrin or Dab2
localization at gap junctions and we do not observe a function for the
myosin-VI–Dab2 complex in clathrin-dependent endocytosis of
annular gap junctions. Instead, we found that myosin VI was
localized at the edge of Cx43 plaques by using total internal
reflection fluorescence (TIRF) microscopy and use FRAP to identify
a plaque accretion defect as the primary manifestation of myosin VI
loss in Cx43 homeostasis. A fuller understanding of this derangement
may explain the cardiomyopathy or gliosis associated with the loss of
myosin VI.
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INTRODUCTION
Cardiac function depends on the precise conduction of electrical
activity throughout the myocardium, and disturbances to this
highly coordinated process are the hallmark of acquired heart
disease. Gap junctions (GJs) are semi-crystalline arrays of double-
membrane-spanning intercellular channels that facilitate action
potential propagation by electrochemically coupling neighboring
cardiomyocytes. The basic subunit of the gap junction is the
connexin, of which there are over 21 types expressed to variable
degrees in nearly all human cell types (Dbouk et al., 2009; Söhl and
Willecke, 2004). Of these, connexin 43 (Cx43; also known as
GJA1) is the most widely expressed and it is the primary gap
junction-forming protein in the ventricular myocardium (Laird,
2006; Severs et al., 2008). Indeed, derangement of the intercalated
disc and Cx43 has been observed in pathological states, including
idiopathic dilated cardiomyopathy, hypertrophy and acute
cardiac ischemia (Kostin et al., 2003, 2004; Sepp et al., 1996;
Smith et al., 1991). As such, Cx43 expression, localization and
post-translational modifications are the subject of continued
investigation.
To form a gap junction, connexin monomers are post-
translationally inserted into the endoplasmic reticulum (ER) and
oligomerized into hexameric transmembrane channels called
connexons in the Golgi (Musil and Goodenough, 1993). By way
of the secretory pathway, connexons are delivered to the plasma
membrane, which they move within until they dock with connexons
from an apposing cell (Lauf et al., 2002). Gap junctions have long
been isolated as double membrane structures, precluding connexon
separation and suggesting that removal of the intercellular junction
requires endocytosis and exocytosis of both membranes in the form
of an annular gap junction (AGJ) (Ghoshroy et al., 1995; Jordan
et al., 2001). Ultimately, internalized AGJs are degraded by
autophagy in a ubiquitin-dependent manner (Bejarano et al.,
2012; Fong et al., 2012). Knowledge of this unidirectional
pathway has long been accompanied by the fact that Cx43
exhibits a surprisingly short half-life for a junctional protein
(ranging from 1.5–5 h), and while rapid turnover facilitates
continuous remodeling, it also leaves connexins particularly
susceptible to trafficking defects (Berthoud, 2004; Fallon and
Goodenough, 1981; Laird et al., 1991). Ultimately, understanding
of molecular mechanisms that govern the delicate balance of gap
junction formation and internalization is paramount to the
maintenance of intercellular communication.
Gap junction regulation is largely controlled by protein–protein
interactions and post-translational modifications involving the Cx43
C-terminal tail. Plaque formation requires phosphorylation by
casein kinase 1 and stabilization depends on the interaction of the
Cx43 C-terminus with the actin-binding scaffolding protein ZO-1
(also known as TJP1) (thereby linking tight and GJs) (Cooper,
2002; Giepmans and Moolenaar, 1998). GJ plaque removal and
decreased gap junction intercellular communication (GJIC) are
associated with many processes, including phosphorylation by both
Src and PKC, ubiquitylation by the protein ligase Nedd4, binding
by the endocytic protein Eps15 and interaction with 14-3-3 proteins
(Catarino et al., 2011; Girao et al., 2009; Smyth et al., 2014; Solan
and Lampe, 2007; Toyofuku et al., 2001).
Historically, the clathrin machinery was also thought to be
required for gap junction internalization. Clathrin and its alternative
adaptor, Dab2, were detected on GFP-labeled Cx43 GJs by
immunofluorescence [although the adaptor protein complex 2
(AP-2) was notably absent] and silencing of clathrin, AP-2, Dab2 or
dynamin caused cells to harbor fewer AGJs (Gumpert et al., 2008;
Piehl et al., 2007). Two tyrosine sorting signals and three
phosphorylation sites within the Cx43 C-terminal tail were
proposed to mediate this process (Fong et al., 2013, 2014). InReceived 28 October 2016; Accepted 4 January 2017
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addition, the Dab2-binding partner myosin VI was also found to
localize to Cx43 GJs and it was suggested that myosin VI plays a
role in the clathrin-mediated endocytosis of GJ plaques. However,
these studies used the no insert (NI) isoform of myosin VI, which
has no reported role in clathrin-mediated endocytosis. Furthermore,
studies have questioned the role of clathrin in the internalization of
double membrane GJs, suggesting that clathrin instead targets
plasma membrane-localized connexons that have yet to form GJs
(Johnson et al., 2013).
Myosin VI is the only unconventional myosin motor protein that
moves toward the minus end of actin filaments, and it is expressed in
four different splice variants in a tissue-specific manner. The large
insert isoform is selectively expressed in polarized epithelial cells,
where it is targeted to the apical domain to facilitate clathrin-
mediated uptake of cell surface receptors (Ameen and Apodaca,
2007; Buss et al., 2001). In contrast, the no insert splice variant is
widely expressed in most cell types and tissues, functioning in cargo
sorting in the endocytic pathway, exocytosis, autophagy and the
regulation of actin filament dynamics (Bond et al., 2011; Chibalina
et al., 2007; Rogat andMiller, 2002; Tumbarello et al., 2012). At the
plasmamembrane, myosin VI functions at the interface between cell
surface proteins and the cortical cytoskeleton, stabilizing cell–cell
adhesion and anchoring apical hair cell membrane to the cortical
actin meshwork (Geisbrecht and Montell, 2002; Heintzelman et al.,
1994; Millo et al., 2004; Self et al., 1999). To mediate this variety of
cellular functions, myosin VI interacts with a broad range of cargo
adaptor proteins that bind to regions in the C-terminal cargo-binding
tail with either an RRL sequence [binding partners GIPC1,
TAX1BP1, NDP52 (also known as CALCOCO2) and optineurin]
or with a WWYmotif (binding partners TOM1, LMTK2 and Dab2)
(Spudich et al., 2006; Tumbarello et al., 2013).
Interestingly, the loss of myosin VI inmice and humansmanifests
as two pathologies affiliated with connexin derangements:
sensorineural deafness and hypertrophic cardiomyopathy
(Avraham et al., 1995; Hegan et al., 2015; Mohiddin et al., 2004;
Williams et al., 2013). In this study, we further investigate the
association of myosin VI with Cx43 GJs in heart tissue and describe
a new role for myosin VI in GJ homeostasis. Previous studies have
separately reported myosin VI localization to GJ plaques in cell
culture models and intercalated discs in heart sections (Karolczak
et al., 2014; Piehl et al., 2007). We show that: (1) myosin VI
recruitment to Cx43 GJs observed in native heart tissue extends to
isolated cardiomyocytes; (2) myosin VI is not required for delivery
of Cx43 to, or its movement within, the plasma membrane; and (3)
loss of myosin VI instead impairs GJ plaque formation and
downregulates intracellular communication.
RESULTS
Myosin VI localizes to GJs in heart tissue and primary
cardiomyocytes
Given previous observations of myosin VI colocalization with its
binding partner Dab2 on GJs in HeLa cells expressing GFP–Cx43
(Piehl et al., 2007), we first examined the subcellular localization of
endogenous myosin VI and Cx43 in the adult mouse heart and
neonatal rat ventricular myocytes (NRVMs). Whole frozen heart
sections were fixed and analyzed by immunohistochemistry. We
detected myosin VI throughout cardiac tissue, and it was enriched
on Cx43 structures at the intercalated disc (Fig. 1A, arrowheads).
We then isolated primary NRVMs and, by immunofluorescence, we
confirmed that myosin VI strongly decorates Cx43 gap junction
plaques (Fig. 1B, arrowheads). Unlike myosin VI, neither Dab2 nor
clathrin localized to Cx43 GJs in our primary cardiomyocyte
experiments using NRVMs (Fig. S1B,C). Western blotting
confirmed that myosin VI is detected in whole-heart homogenates
(Fig. S3A) and purified cardiomyocytes (Fig. S1A).
In addition to primary heart tissue, we also used normal rat kidney
(NRK) cells, which endogenously express Cx43 and myosin VI, to
confirm the colocalization of these proteins. Using retroviral
transduction, we created cell lines stably expressing Cx43–
TagRFP-t, in which we transiently expressed HaloTag (HT)-
conjugated myosin VI. HT–myosin-VI strongly colocalized with
Cx43–TagRFP-t-labeled GJs (Fig. 1C, arrowheads), thus
supporting the localization of myosin VI at GJs observed in
whole-heart sections and primary NRVMs.
Myosin VI recruitment to Cx43 GJs requires the RRL binding
motif
Myosin VI is composed of a conserved catalytic domain and a
C-terminal cargo-binding domain that contains ubiquitin- and lipid-
binding domains and mediates binding to adaptor proteins via RRL
and WWY motifs (Fig. 2A) (Chibalina et al., 2007; Morriswood
et al., 2007; Sahlender et al., 2005; Tumbarello et al., 2012). To
determine which binding domain and potential adaptor protein are
required for myosin VI localization to Cx43 GJs, we transfected
NRK cells stably expressing Cx43–TagRFP-t with GFP–myosin-VI
full-length constructs (Fig. 2B) harboring amino acid substitutions
known to disrupt these binding domains. Fixed cell fluorescence
microscopy demonstrated that the ΔWWYmutant mimics wild type
localization of myosin VI to Cx43 (arrowheads), while the loss of the
RRL binding motif prevented myosin VI targeting to Cx43 (arrows).
To confirm this observation, line plots drawn through GJ plaques
were quantified as depicted (Fig. 2C). Line plots were oriented with
the GFP–myosin-VI-expressing cell to the right. While not included
in Fig. 2B, motor domain (A600V and K157R) and ubiquitin-
binding (A1013G) mutants were also tested for GJ recruitment.
Myosin VI fluorescence intensity reached a local maximum at the
Cx43 GJ plaque center (0 µm) in all plots except RRL mutants
(Fig. 2D). These results clearly establish that myosin VI localization
to Cx43 GJs does not depend on motor activity, the A1013
ubiquitin-binding site or the WWY-binding partners TOM1,
LMTK2 or Dab2.
We then asked if the RRL-binding partners OPTN, TAX1BP1 or
GIPC1 also localize to Cx43 GJs. NDP52 was omitted because
rodents express a truncated isoform that lacks the myosin VI-
binding zinc finger domain (Tumbarello et al., 2015). In fixed
primary NRVMs, antibodies raised against OPTN, TAX1BP1 and
GIPC1 failed to decorate Cx43 GJ plaques (Fig. S2A, arrowheads).
We obtained the same result using NRK cells stably expressing
Cx43–TagRFP-t and HT–myosin-VI transfected with GFP–OPTN,
GFP–TAX1BP1 or GFP–GIPC1 (Fig. S2B, arrowheads). These
results suggest that myosin VI targets to Cx43 either directly, via an
unknown binding partner or ubiquitin binding through the MyUb
domain – a recently described region that overlaps with the RRL
binding region (He et al., 2016).
Myosin VI depletion leads to a reduction in GJ plaque size
To investigate the ramifications of myosin VI loss on GJ
maintenance and morphology, we isolated heart tissue from the
Snell’s waltzer (sv) myosin VI-null mouse. While blotting whole-
heart homogenates showed only a subtle decrease in total Cx43
(Fig. S3A,B), a selective loss of Cx43 from the plasma membrane is
observed by immunohistochemistry in fixed sv hearts. In the myosin
VI-null heart, Cx43 still localized to the intercalated disc, but
individual Cx43 structures were smaller (Fig. 3A). Quantification of
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all Cx43 structures in sv hearts (between 26,000 and 47,000 per
heart) verified this reduction in average Cx43 area compared to
wild-type hearts (Fig. 3B).
We also depleted myosin VI by using siRNA in RPE cells and
HeLa cells stably expressing Cx43. As we observed for whole-heart
homogenates, the knockdown of myosin VI in HeLa cells
(Fig. S3C) did not lead to a marked change in total Cx43;
however, fixed cell fluorescence showed a reduction in the Cx43–
GFP-labeled GJ plaque size when myosin VI was silenced in HeLa
stable cell lines (Fig. 3C). Quantification of all Cx43 GJ plaques
from these images (Fig. 3D) confirmed that the average plaque size
is reduced when myosin VI is silenced.
To further corroborate these observations, we isolated and
immortalized mouse embryonic fibroblasts (MEFs) from wild-
type and svmice. Here, western blotting for Cx43 (Fig. 3E) showed
a sizeable reduction in the amount of total Cx43 in sv MEFs
(Fig. 3F). By immunofluorescence, we again observed a decrease in
Cx43 GJ plaque size when myosin VI was lost (Fig. 3G).
Quantification of these microscopy experiments verified this
observation (Fig. 3H). These results indicate that the primary
effect of myosin VI loss is a reduction in Cx43 GJ plaque size in
heart tissue, HeLa cells and immortalized sv MEFs.
Myosin VI depletion impairs GJ intercellular communication
We then asked whether the reduction in GJ plaque size is associated
with a concomitant reduction in GJIC in myosin VI-null cells. For
these experiments, we used the BioPen microfluidic pipette (Ainla
et al., 2010) to generate a hydrodynamically confined fluid sphere to
selectively load multiple cells with calcein AM (Fig. 4A), which
converts into a GJ-permeable dye within cells. To demarcate the
zone of calcein AM administration, 1 µg/ml wheat germ agglutinin
conjugated to Alexa Fluor 647 (WGA–647) was added to a solution
of 20 µM calcein AM and cells were loaded for 10 min (Fig. 4B).
After 60 min, a tiled image of the administration site was obtained,
Fig. 1. Myosin VI localizes to Cx43 GJs. (A) Heart sections and (B) isolated NRVMs were processed for confocal immunofluorescence microscopy to assess
endogenous Cx43 (green) andmyosin VI (MVI, red) colocalization. Nuclei were labeled with Hoechst 33342 (blue) and F-actin was labeled with Alexa-Fluor-647–
phalloidin (white). (C) Live NRK cells stably expressing GFP–myosin-VI (green) and Cx43–TagRFP-t (red) were imaged on a Nikon spinning disk microscope.
Arrowheads identify myosin VI localization to Cx43 plaques at intercellular junctions. Scale bars: 10 µm.
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showing that svMEFs transfer substantially less calcein AM across
a monolayer compared to wild-type cells (Fig. 4C). To quantify this
difference, line plots were drawn across the calcein administration
zone and the intensities were averaged for each channel (Fig. 4D).
Line plots from multiple experiments were normalized, averaged
and plotted for WGA–647 (Fig. 4E) to confirm equivalent
administration of calcein AM. In contrast, calcein AM spread
(Fig. 4F) was much lower in sv MEFs compared to wild-type cells.
To confirm these findings and to verify this new method, we
also conducted fluorescence recovery after photobleaching
Fig. 2. Myosin VI targets to Cx43 GJs through the RRL motif in the myosin VI cargo-binding tail domain. (A) Cartoon depicting the domain structure of
myosin VI (MVI). Myosin VI contains a catalytic motor domain, a unique insert (green), an IQ calmodulin-binding motif (orange), a tail region containing a three-
helix bundle and a single α-helix (SAH) domain (light blue), and a cargo-binding tail domain (dark blue). The cargo-binding tail contains protein interaction
motifs (RRL andWWY) as well as binding regions for ubiquitin and phosphatidylinositol 4,5-bisphosphate. Alternative splicing can give rise to insertions of both a
large and small insert (LI, SI). (B) NRK cells stably expressing Cx43–TagRFP-t (red) were transfected with full-length GFP–myosin-VI (green) constructs with
point mutations, fixed and processed for confocal microscopy. Visually, colocalization was lost in the ΔRRL and ΔWWY/ΔRRL mutants (arrows) compared to
the wild type (WT) and ΔWWYmutant (arrowheads). (C) 4-µm line plots for GFP and TagRFP-t fluorescence were then drawn across all Cx43 GJs (illustrated for
the boxed region from B) toward the center of the GFP–myosin-VI -expressing cell. (D) Channel intensity for myosin VI (dashed lines indicate ±s.e.m.) was plotted
for each GJ and averaged for at least 256 plaques in at least 30 cells for each mutant. Neither the ΔRRL nor the ΔRRL/ΔWWYmyosin VI mutant showed a peak in
intensity at Cx43 GJs. Scale bar: 10 µm.
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(FRAP) experiments (Abbaci et al., 2007; Bastide et al., 1995)
with wild-type and sv MEFs. In accordance with our micropipette
loading assay, calcein AM fluorescence recovery as calculated by
linear regression analysis (Santiquet et al., 2012) was reduced
when myosin VI was lost (Fig. 5A). In this analysis, total
fluorescence recovery (Fig. 5B) was decreased in the absence of
myosin VI, but the more striking effect was a decrease in the rate of
fluorescence recovery (Fig. 5C). These results indicate that the
reduction in GJ size due to myosin VI loss corresponds with
defective GJIC.
Fig. 3. The loss of myosin VI results in reduced GJ size. (A) Whole-heart sections from wild-type (WT) and sv (SV) mice were processed for confocal
immunofluorescencemicroscopyand immunostained forCx43 (green)andstained forF-actin (white). (B)Cx43GJplaqueswere identifiedandquantified for twopairs of
hearts (26,000–47,000 structures per heart). ****P<0.0001; ns, not significant. (C) Confluent monolayers of HeLa cells stably expressing Cx43–GFP (green)
were transfected with non-targeting or myosin VI siRNA, stained for F-actin and imaged. (D) GJ plaque area was quantified using ImageJ (mean±s.d., n=3).
****P<0.0001. (E) Immunoblot forCx43andmyosinVI inWTandsvMEFs. (F)QuantificationofwesternblotCx43 intensitynormalizedbyBio-RadStain-Free tryptophan
labeling (total protein) (mean±s.d., n=5). *P<0.05. (G) WT and svMEFs were processed for confocal immunofluorescence microscopy and immunostained for Cx43
(green). Arrowheads indicate GJ plaques inWT and SV cells. (H) Cx43 GJ plaque areawas quantified using ImageJ. (mean±s.d., n=3). **P<0.01. Scale bars: 10 µm.
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Plaques accumulate more slowly without myosin VI, but not
due to defective Cx43 forward trafficking
Considering known roles for myosin VI in protein secretion, we next
investigated whether the forward trafficking of Cx43 from the ER to
the plasma membrane was delayed in myosin VI-depleted cells
(Bond et al., 2011; Chibalina et al., 2010). We first analyzed the
formation of endogenous GJ plaques in svMEFs using a brefeldin A
(BFA) forward trafficking assay. Treatment with BFA induces a
Fig. 4. Gap junction intercellular communication is reduced inmyosin VI-null MEFs. (A) Cartoon detailing an assay to measure GJIC. We used the BioPen
microfluidic pipette to administer 20 µM calcein AM and 1 µg/ml WGA to monolayers of wild-type (WT) and sv (SV) MEFs for 10 min. The total spread of calcein
AM through GJs was measured 60 min later. (B) Calcein AM (green) and WGA (red) loading was imaged using live-cell spinning disk microscopy over 10 min.
(C) Tiled images surrounding the site of administration (WGA, grayscale) were obtained 60 min later to visualize the extent of transfer of calcein (Fire LUT).
(D) Cartoon depicting the quantification method in which line scans were drawn across cell monolayers. A rotated image from C is re-shown for demonstrative
purposes. Signal intensities across each sample were averaged and plotted for WGA–647 (E) and Calcein AM (F) (dashed lines indicate ±s.e.m., n=3).
Scale bars: 10 µm.
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reversible inhibition of COPI-mediated transport from the ER to the
Golgi. Wild-type and sv MEFs were treated with 5 µg/ml BFA for
6.5 h, resulting in accumulation of Cx43 in the ER. BFA washout
restored transport and cells were fixed 1, 2 or 3 h later. One hour
after washout, the vast majority of Cx43 had left the ER and
localized to the Golgi. Three hours after washout, Cx43 had
trafficked to the cell surface and GJ plaques accumulated between
cells (Fig. 6A). Interestingly, our results demonstrate that after
restoring the secretory pathway with BFAwashout, the intracellular
GJ plaques grow at a slower rate and remain smaller in sv MEFs
compared to wild-type MEFs (Fig. 6A,B).
To assess whether loss of myosin VI causes any delays in the
trafficking of Cx43–GFP through the secretory pathway, we also
used the retention using selective hooks (RUSH) system
(Boncompain et al., 2012) to control and synchronize Cx43–GFP
release from the ER, since the folding and maturation time inherent
to GFP makes it difficult to observe the early secretory itinerary of
Cx43–GFP. We created a Cx43 fusion protein tagged with an N-
terminal GFP and streptavidin-binding protein (SBP–GFP–Cx43)
that was expressed under the same promoter as core streptavidin
anchored to the ER using the major histocompatibility complex
(MHC) invariant chain (Ii). In this system, SBP–GFP–Cx43 is
retained in the ER, but upon biotin addition, SBP–GFP–Cx43 freely
traffics through the secretory pathway (Fig. 6C).
We first co-expressed HT–myosin-VI and SBP–GFP–Cx43
(Fig. S4A) in NRK cells to determine whether these proteins
colocalized throughout SBP–GFP–Cx43 trafficking. Before the
addition of biotin, SBP–GFP–Cx43 was confined to intracellular
puncta that lacked myosin VI labeling. At 25 min after biotin
addition, most SBP–GFP–Cx43 was confined to the Golgi, where
no myosin VI was present. At 50 min minutes after biotin addition,
SBP–GFP–Cx43-containing trafficking intermediates en route to
the plasma membrane were observed, and these were also devoid of
myosin VI (arrowheads, Fig. S4A).
These results suggest that myosin VI does not play a role in SBP–
GFP–Cx43 forward trafficking, but to validate this observation, we
conducted similar experiments in wild-type and svMEFs (Fig. 6D).
Upon biotin addition, ER-localized SBP–GFP–Cx43 trafficked to
the Golgi, accumulating there within 25 min in both cell types
(Fig. 6D). During this period, there appeared to be no qualitative
difference in the trafficking of SBP–GFP–Cx43, suggesting myosin
VI is not required for movement of Cx43 through the secretory
pathway.
Myosin VI contributes to Cx43 accretion at GJ plaques
To further assess whether loss of myosin VI causes a defect in Cx43
trafficking to the cell surface, we quantified the plasma membrane-
localized population of Cx43 connexons using a surface
biotinylation assay in wild-type and sv MEFs. While total Cx43
was markedly reduced in svMEFs, the amount of Cx43 connexons
in the plasma membrane was not significantly different compared to
wild-type MEFs (Fig. 7A,B). Since less Cx43 is incorporated into
GJ plaques in svMEFs compared to wild-type cells (see Fig. 3G,H),
it follows that these cells contain a larger fraction of free Cx43 in the
plasma membrane as compared to wild-type MEFs.
We next performed single-particle-tracking photoactivation
localization microscopy (sptPALM) in wild-type and sv MEFs
expressing a monomeric (m)EOS3–Cx43 fusion protein to test
whether there were differences in the mobility of the free molecules
in the plasma membrane of these cells. As shown in Fig. 7C, no
difference in mEOS3–Cx43 mobility outside of plaques was seen in
the two cell types, indicating myosin VI depletion does not affect
free Cx43 movement in the plasma membrane (Fig. 7C).
We then addressed whether myosin VI serves a role in GJ plaque
stability or biogenesis, since our localization studies show a strong
enrichment of myosin VI on Cx43 GJs. We noticed that on rare
occasions, Cx43 GJ plaques extend close to the coverslip. This
allowed us to take advantage of the reductions in the out-of-focus
light that total internal reflection fluorescence (TIRF) microscopy
affords. Using this technique, we imaged NRK cells transfected
with Cx43–GFP and HT–myosin-VI, observing that HT–myosin-
VI localizes to the edge of GJ plaques (arrowhead, Fig. 7D;
Movie 1). To investigate Cx43 GJ accretion (i.e. assembly into a GJ
plaque), we used a photobleaching assay in wild-type or sv MEFs
transfected with Cx43–GFP. A small portion of a large Cx43–GFP
plaque was photobleached as indicated (Fig. 7E, dotted white box)
and imaged 40 min later to test for recovery of Cx43–GFP
fluorescence in this area. In wild-type MEFs, partial recovery at
the plaque edge was observed (see arrowheads in WT panel),
suggesting that free Cx43–GFP molecules were undergoing
accretion at the plague edge over time. In sv cells, by contrast,
much less Cx43–GFP was seen accumulating at plaque edges
(Fig. 7E,F), suggesting a defect in the ability of Cx43 to be recruited
into the plaque.
DISCUSSION
In this study, we used new and traditional assays of GJ trafficking
and function to redefine numerous aspects of the role of myosin
VI in Cx43 GJ homeostasis. First, we confirmed a previous report
that endogenous myosin VI localizes to GJs in heart tissue
Fig. 5. Loss of myosin VI compromises GJ intercellular transport.
(A) Wild-type (WT) and sv (SV) MEFs were loaded with calcein AM and
cells were photobleached for FRAP analysis. Fluorescence recovery as a
function of time was plotted (mean, ±s.e.m. is indicated by the region between
the dashed lines, n=3). (B) Quantification of fluorescence intensity at t, F∞
as calculated by linear regression analysis (mean±s.d., n=3). *P<0.05.
(C) Quantification of recovery rate. (mean±s.d., n=3). ****P<0.0001.
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(Karolczak et al., 2014) and we extended this finding to primary
mouse cardiomyocytes and identified the RRL or MyUB binding
motif as the basis of this localization. Second, we showed that the
loss of myosin VI leads to a reduction in GJ plaque size not only in
myosin VI siRNA HeLa knockdown cells but also in cardiac
tissue and fibroblasts from the Snell’s waltzer mouse. Third,
we observed a concomitant reduction in GJ intercellular
communication using a new method of selective calcein
administration. Finally, we found that the observed reduction in
GJ size was not due to the defective delivery of Cx43 to the cell
surface via the biosynthetic pathway but instead was caused by
impaired plaque accretion (Fig. 8).
Prior work has suggested that localization of myosin VI at GJ
plaques is linked to its role in GJ internalization by a clathrin- and
Dab2-mediated process (Piehl et al., 2007). While our work
confirms myosin VI localization at GJs in primary cardiac tissues
and isolated cardiomyocytes, it also suggests that this localization is
not involved in GJ internalization. None of our cells showed clathrin
or Dab2 localized at GJ plaques. Moreover, we found that WWY
motif of myosin VI (which interacts with Dab2) is dispensable to GJ
localization of myosin VI. Therefore, myosin VI function at GJs is
unlikely to be related to clathrin-mediated endocytosis.
This conclusion is consistent with the fact that the cells used in
the Piehl et al. study did not express the LI isoform of myosin VI that
Fig. 6. Cx43 GJ plaque formation is reduced in myosin VI-null MEFs, but Golgi trafficking remains intact. (A) Wild-type (WT) and sv (SV) MEFs were
treated for 6.5 h with 5 µg/ml Brefeldin A (BFA). Cells were fixed after washout periods of 0, 1, 2 or 3 h, processed for confocal immunofluorescence microscopy
and immunostained for Cx43 (grayscale) to identify GJ plaques (arrowheads). (B) GJ plaque area was quantified using ImageJ (mean±s.d., n=3). *P<0.05,
**P<0.01. (C) Cartoon depicting the RUSH trafficking assay. Upon the addition of biotin to the medium, GFP–Cx43 fused to streptavidin-binding peptide (SBP–
GFP–Cx43) is displaced from the ER retention hook (core streptavidin anchored to an invariant chain of the major histocompatibility complex, Ii–STV). SBP–
GFP–Cx43 then freely traffics from the ER, through the Golgi, to the plasma membrane. (D) Wild-type and Snell’s waltzerMEFs were transiently transfected with
SBP–GFP–Cx43 – a bicistronic construct that also contains the ER hook. Biotin was added to the medium and cells were imaged on a Nikon spinning disk
microscope to follow SBP–GFP–Cx43 trafficking. Scale bars: 10 µm.
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is involved in clathrin-mediated endocytosis (Aschenbrenner et al.,
2003; Buss et al., 2001). The putative Dab2-binding motif (xPxY)
that exists in the Cx43 tail, therefore, may be more important for
Cx43 hemichannel rather than plaque endocytosis.
In our studies examining myosin VI recruitment to GJs, we
identified a requirement of the RRL binding motif on myosin VI,
but known RRL-binding partners –OPTN, TAX1BP1 and GIPC1 –
failed to localize to GJ plaques. This raises the possibility that
Fig. 7. Plasma membrane-localized Cx43 exhibits an accretion defect in myosin VI-null MEFs. (A) The surface of wt and sv (SV) MEFs was biotinylated at
4°C and biotinylated proteins were isolated using NeurtrAvidin beads. Whole-cell lysates and biotinylation fractions were immunoblotted with an antibody against
Cx43. MVI, myosin VI. (B) Quantification of western blot Cx43 intensity normalized by Bio-Rad Stain-Free tryptophan labeling (total protein) (mean±s.d., n=3).
****P<0.0001; ns, not significant. (C) Wild-type and sv MEFs were transfected with mEOS3–Cx43 and imaged on a Nikon TIRF microscope for single-particle-
tracking photoactivation localization microscopy analysis. The diffusion coefficient of mobile mEOS3–Cx43 (Cx43 D250ms; mean±s.d.) was quantified for at least
seven cells for each phenotype. (D) NRK cells stably expressing Cx43–GFP (green) and HT–myosin-VI were incubated with the JF646-HaloTag ligand (red)
before imaging using TIRF microscopy to identify peripheral recruitment of myosin VI to Cx43 GJ plaques (arrowheads). (E) WT and sv MEFs were transfected
with Cx43–GFP (Fire LUT) and imaged using a 3i Spinning Disk microscope for FRAPexperiments. Square regions of Cx43 plaques were photobleached (dotted
box) and imaged over 40 min to measure Cx43 accretion. WTMEF accretion (arrowhead) was greater than that observed in svMEFs (arrows). (F) Cx43 accretion
was quantified using ImageJ (mean±s.d., n=4). *P<0.05. Scale bars: 10 µm.
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myosin VI targets to GJs by some other binding partner.
Alternatively, since recent studies suggest that myosin VI harbors
a second ubiquitin-binding motif, which overlaps with the RRL
binding site and is disrupted by the ΔRRL mutant (He et al., 2016),
it is possible that interactions with ubiquitylated substrates
(including ubiquitylation sites in the Cx43 C-terminal tail)
determine myosin VI localization to GJs.
Regardless of the recruitment mechanism, we observed a striking
reduction in GJ plaque size when myosin VI was lost in HeLa cells
stably expressing Cx43–GFP, sv MEFs and sv cardiac tissue.
Furthermore, loss of myosin VI led to reduced intercellular
communication. Traditionally, GJIC is assessed by scrape-loading
cells with Lucifer Yellow, photobleaching calcein-loaded cells or
seeding calcein-loaded cells onto a monolayer of cells (Abbaci et al.,
2008). While widely used, scrape-loading requires cellular
disruption and drop-in assays require normal GJ formation. The
latter two techniques are single-cell assays and are laborious.
Microfluidic chip strategies have been devised to obtain population-
level GJIC data with minimal cellular disruption (Bathany et al.,
2011), but these techniques require advanced microfluidics
experience. Instead, we employed the BioPen, a highly compatible
microfluidic pipette, to gently and selectively load cells with calcein
AM.With this method, we measured GJIC across more than 20 cells
per experiment and showed that significantly less calcein AM
diffused across cell monolayers in sv MEFs (with equal loading
confirmed by WGA staining). Given the novelty of this assay, we
also conducted calcein FRAP experiments to confirm this defect.
To determine the mechanism of GJ plaque reduction with myosin
VI loss, we first used a brefeldin A forward trafficking
synchronization assay to show that plaque re-formation was
defective in myosin VI-null MEFs. At 1 h after BFA washout,
similar amounts of Cx43 had accumulated within the Golgi, but
plaque growth was decreased in myosin VI-null cells. We also used
the RUSH system to create a Cx43 construct that we could use to
observe Cx43 forward trafficking using live-cell microscopy fully.
Using the RUSH assay, we did not observe any myosin VI-
dependent delays in Cx43 trafficking throughout the secretory
pathway. This dispensability of myosin VI in the forward trafficking
of vesicular Cx43 is consistent with reports of targeted delivery to
adherens junctions by microtubules and the plus-end-tracking
protein EB1 (also known as MAPRE1) (Shaw et al., 2007).
To characterize plasma membrane-localized Cx43, we used
sptPALM to show that myosin VI loss did not affect Cx43
diffusional mobility in non-plaque areas. TIRF microscopy further
demonstrated a selective recruitment of myosin VI to the edges of
GJ plaques, and indeed, quantification of Cx43 accretion after
photobleaching of plaques showed defective Cx43 plaque accretion
when myosin VI was lost. These findings suggest an alternative to
the prevailing endocytosis model of myosin VI function in GJ
homeostasis, with myosin VI instead functioning to deliver Cx43
molecules into plaques, facilitating the established role of actin in
this process (see Fig. 8).
Actin-containing microfilaments and GJs have been long
observed in close proximity to each other (Larsen et al., 1979).
To date, Cx43 linkages to actin include the tight junction protein
ZO-1 and the actin-binding protein drebrin. Studies have shown that
both dominant-negative ZO-1 and drebrin silencing by siRNA
cause Cx43 loss from the intercellular junction and reduced cell
communication (Butkevich et al., 2004; Toyofuku et al., 1998).
Furthermore, actin polymerization inhibition by cytochalasin D has
been shown to reduce dye transmission between cells and impede
recovery of photobleached Cx43 GJ plaques (Martin et al., 2001;
Thomas et al., 2001). Other studies have claimed that actin
depolymerization also reduces plaque formation (Shaw et al., 2007).
To date, an association of hypertrophic cardiomyopathy with
myosin VI loss has been described for a number of patients and two
different mouse models (Avraham et al., 1995; Mohiddin et al.,
2004; Williams et al., 2013). Numerous studies have investigated
the expression and localization of myosin VI in skeletal muscle
throughout myotube differentiation and in response to denervation,
but investigations in cardiac muscle have been less robust
(Karolczak et al., 2013, 2015). One study confirmed an increase
in the heart-weight-to-body-weight ratio in sv mice, and found that
the absence of myosin VI caused an increase in interstitial fibrosis
that was unrelated to mouse age; however, this investigation focused
on myosin VI expression in vascular endothelial cells of the heart
and lungs and did not comment on myosin VI localization to the
intercalated disc as previously described (Hegan et al., 2015;
Karolczak et al., 2014).
In summary, this work identifies a new role for myosin VI in the
construction and maintenance of GJ plaques between cells, setting
the stage for further investigations into other connexin
derangements. Mice lacking myosin VI had a modest reduction in
the GJ intercalated disc size in their hearts, so it will be interesting to
assess the maintenance of Cx43 homeostasis, including Cx43
Fig. 8. Myosin VI facilitates Cx43 GJ accretion. Our experiments showed
that myosin VI did not localize together with Cx43 along the biosynthetic
pathway, and that loss of myosin VI did not affect Cx43 delivery to or trafficking
within the plasma membrane. We also did not observe clathrin and Dab2
localization colocalization with Cx43 at the plasma membrane. Instead, by
using TIRF microscopy, we visualized myosin VI at the periphery of Cx43 GJ
plaques, and by using FRAP, we observed an Cx43 accretion defect when
myosin VI was lost. We hypothesize that it is at the GJ plaque edge that myosin
VI aids in actin-mediated Cx43 accretion.
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accretion rates into GJs, in response to pathological insults such as
ischemia and chronic elevations in afterload. Apart from the heart,
Cx43 is also the major connexin expressed in other cell types –
namely, astrocytes. The sv mice have been reported to display a
profound reactive astrogliosis (Osterweil et al., 2005), so it will be
interesting to see whether this is linked to reduced GJ function in
reactive astrocytes in the brain.
MATERIALS AND METHODS
Reagents and antibodies
Affinity-purified rabbit antibodies against myosin VI, TAX1BP1 and
optineurin were generated as previously described (Buss et al., 1998;
Morriswood et al., 2007; Sahlender et al., 2005). Commercial antibodies
against the following proteins were used: Cx43 [C6219; 1:200
immunofluorescence (IF), 1:2000 western blotting (WB)] and actin
(A2066; 1:5000 WB) polyclonal antibodies (Sigma), Cx43 (05-763;
1:200 IF) monoclonal antibody (Millipore), GAPDH (6C5; 1:1000 WB)
and clathrin (X22; 1:100 IF) monoclonal antibodies (Abcam), Dab2 (H-110;
1:100 IF) and GIPC1 (N-19; 1:100 IF) polyclonal antibodies (Santa Cruz
Biotechnology) and pan-cadherin (4068; 1:1000 WB) polyclonal antibody
(Cell Signaling). Phalloidin–Alexa-Fluor-647, Calcein AM,WGA–647 and
Hoechst 33342 were purchased from ThermoFisher. Bafilomycin A1,
brefeldin A and biotin were purchased from Sigma-Aldrich. JF646-HaloTag
ligand was a kind gift from Joel Slaughter and Luke Lavis (Janelia Farm,
HHMI, Ashburn, VA) (Grimm et al., 2015).
Cell culture and transfections
HeLa cells were cultured in RPMI, while NRK cells (CRL-1570) andMEFs
(prepared as previously described in Tumbarello et al., 2012) were cultured
in Dulbecco’s modified Eagle’s medium (DMEM). RPE cells (CRL-2302)
were cultured in DMEM:Ham’s F-12 (50:50) and 30 mM sodium
bicarbonate. All media were supplemented with 10% fetal bovine serum
(FBS), 2 mM glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin.
All cell lines were periodically confirmed to bemycoplasma free by Hoechst
33342 fluorescence microscopy.
cDNA transfections were performed according to the manufacturer’s
instructions by using FuGENE (Promega) for HeLa cells and Lipofectamine
3000 (Invitrogen) for all other cells. For traditional calcein AM loading, cells
were incubated with 0.5 μM calcein AM for 30 min before washing with
complete growth medium. For brefeldin A forward trafficking assays, cells
were incubated in 5 μg/ml brefeldin A for 6.5 h followed by a chase in
complete medium for the indicated times. Bafilomycin A1 treatment was
conducted at a concentration of 100 nM for 6.5 h. For surface biotinylation,
the Pierce cell surface protein isolation kit was used according to the
manufacturer’s instructions. For RUSH trafficking experiments, biotin was
added to themedium to a final concentration of 40 µM at the time of imaging.
For HaloTag ligand conjugation, the far-red JF646-HaloTag ligand (HTL)
was diluted 1:200 and then 1:5 in complete medium. Cells were incubated in
JF646-HTL-containing medium for 20 min at 37°C and washed multiple
times with complete medium before imaging. Once conjugated, sample
handling was identical to that for proteins tagged with fluorescent proteins
as above.
Myosin VI ON-TARGET plus SMARTpool siRNA oligonucleotides (as
previously described in Tumbarello et al., 2012) were purchased from
Dharmacon and transfected into cells using Oligofectamine (ThermoFisher)
according to the manufacturer’s instructions. For efficient knockdown of
myosin VI, cells were transfected on days one and three before processing
on day five. Efficiency of depletion was assessed by western blotting.
Primary culture of neonatal rat ventricular myocytes
All experiments were conducted in accordance with the United Kingdom
Animals (Scientific Procedure) Act of 1986. NRVMs were established from
wild-type and Snell’s waltzer neonatal mouse pups. Surgically removed
hearts were stored in ice-cold PBS and isolated ventricles were incubated in
0.5% trypsin-EDTA overnight with constant shaking. The following day,
ventricles werewarmed in NRVMmedium (500 ml medium 199 plus 2 mM
L-glutamine, 10 mM HEPES, 100 μM non-essential amino acids, 1.75 g
glucose, 10 μg/ml vitamin B12 and penicillin-streptomycin) supplemented
with 10% FBS and digested with type II collagenase (Sigma) (1 mg/ml in
HBSS). Three collagenase fractions were added to HBSS on ice,
centrifuged, resuspended and strained with a 70 μm cell strainer (Fisher).
Single cells were resuspended in warm NRVMmedium with 10% FBS and
plated on a 10 cm dish to isolate fibroblasts. 90 min later, enriched
cardiomyocytes were plated at a concentration of 106 cells/well (for a 12-
well dish) on fibronectin-coated coverslips (Sigma). On subsequent days,
NRVMs were washed with NRVM medium supplemented with 2% FBS
and imaged within 2 days.
Plasmids
GFP–myosin-VI constructs and mutants were generated as previously
described (Arden et al., 2007; Chibalina et al., 2007; Tumbarello et al.,
2012). GFP–optineurin, GFP–TAX1BP1 and GFP–GIPC1 were generated
as previously described (Morriswood et al., 2007; Sahlender et al., 2005).
Cx43–TagRFP-t and Cx43–GFP were constructed by subcloning the
respective fluorescent proteins into Cx43-mApple, a kind gift fromGeoffrey
Hesketh (University of Cambridge, UK). mEOS3–Cx43 was constructed by
cloning Cx43 into a C-terminal mEOS3 vector, a kind gift from Prabuddha
Sengupta (NICHD, NIH, Rockville, MD). HaloTag–myosin-VI was created
by cloning myosin VI into a HaloTag vector C (Promega). SBP–GFP–Cx43
was created by first cloning Cx43 into a C-terminal GFP vector (Clontech)
and then inserting GFP–Cx43 into a C-terminal SBP-tagged RUSH
construct, a kind gift from Aubrey Weigel (NICHD, NIH, Rockville,
MD). Stable cell lines were generated by amphotropic retroviral transduction
of the above constructs cloned into the pLXIN retroviral vector, G418
selection and enrichment through fluorescence activated cell sorting
(courtesy of the National Eye Institute Flow Cytometry Core).
Western blotting
Cell monolayers were lysed in 2× Laemmli sample buffer and boiled for
5 min prior to SDS-PAGE using Mini-PROTEAN TGX Stain-Free precast
gels (Bio-Rad). After gel activation, as per the manufacturer’s instructions,
proteins were transferred to a low fluorescence PVDFmembrane (Bio-Rad),
blocked and incubated with primary and secondary antibodies (given
above). Membranes were then incubated for 5 min in the Clarity enhanced
chemiluminescence western blotting substrate (Bio-Rad) and imaged on a
Bio-Rad ChemiDoc. The integrated intensity of immunolabeled protein
bands was calculated using Bio-Rad Image Lab software and normalized by
Bio-Rad stain-free UV tryptophan labeling.
Immunofluorescence
Cells were grown on glass coverslips (Carl Zeiss) or in Nunc Lab-Tek
coverglass chambers (ThermoFisher). Cells were washed with PBS, fixed
with 4% formaldehyde (Electron Microscopy Services) and permeabilized
with 0.2% Triton X-100 (Sigma) in PBS. Fixed cells were blocked with
1% bovine serum albumin (BSA) before incubation with primary
antibodies and detection using Alexa Fluor 488- or 568-conjugated
secondary antibodies and 647-conjugated phalloidin (Invitrogen).
Coverslips were mounted on slides using ProLong Anti-fade mounting
medium (ThermoFisher) and Lab-Tek coverglasses were covered with
PBS. Images were acquired on a Nikon Ti3 spinning disk system operated
by Nikon Elements software.
Whole hearts were fixed in 4% formaldehyde and cryoprotected with
10% and 30% sucrose. Hearts were embedded in OCTmedium, flash-frozen
in liquid nitrogen, sectioned on a Leica CM1850 cryostat and mounted on
chilled slides. Mounted heart sections were post-fixed in 4% formaldehyde,
permeabilized in 0.2% Triton X-100 and blocked in 3% BSA. Blocked
samples were incubated in primary antibodies at 4°C and the next day,
samples were incubated in secondary antibodies and mounted on coverslips
with ProLong Gold (ThermoFisher). Images were acquired on a Zeiss
LSM710 confocal microscope operated by Zeiss ZEN software.
Live-cell imaging
Cells were grown on Lab-Tek coverglass chambers, glass-bottom dishes
(MatTek) or 15-mm round coverslips under normal conditions. Cells were
imaged on a Nikon Ti3 spinning disk or a 3i spinning disk system. All
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systems were equipped with temperature regulation, while the Nikon system
was also equipped with CO2 control. For 3i imaging, phenol red-free
DMEM supplemented with 2 mM L-glutamine, 10% FBS and 20 mM
HEPES was used. TIRF microscopy was conducted on a Nikon Ti3 TIRF
system with an Andor EMCCD camera. For this imaging modality, #1.5
coverslips were coated with 20 μg/ml fibronectin (Millipore).
FRAP studies
FRAP studies were conducted using a 3i spinning disk microscope and 3i
SlideBook software. For GJIC studies, single cells were photobleached with
405 nm wavelength light and imaged for 10 min to measure fluorescence
recovery. Calcein recovery was quantified using ImageJ. Specifically, three
regions of interest (ROIs) were measured over time: the photobleached ROI,
ROI(t); the whole-cell ROI, Tot(t); and an ROI for background fluorescence
intensity, BG(t). For each time point, the background intensity was removed,
photobleaching was accounted for by dividing the photobleached ROI by
the whole-cell ROI and each time point was normalized by the initial
intensity (Eqn 1). Normalized values were plotted over time.
ROIðtÞ  BGðtÞ
TotðtÞ  BGðtÞ 
Totðt0Þ  BGðt0Þ
ROIðt0Þ  BGðt0Þ ð1Þ
For GJ plaque FRAP experiments, a square region of a GJ plaque was
photobleached with 405 nm light and plaques were imaged every 5 min for
40 min. Cx43 plaque accretion was quantified manually using ImageJ to
calculate the mean pixel intensity at the growing plaque edge.
Micropipette-assisted calcein loading
Amicrofluidic pipette (BioPen, Fluicell) controlled by a micromanipulation
apparatus (Eppendorf ) was used to selectively load a region of cells. Using
an administration pressure of 200 mBar, a solution containing Alexa Fluor
647 (ThermoFisher) was first used to demarcate the fluid sphere. The
micropipette was lowered until the area of dye fit inside the 60× field of view
and matched that administered for other samples. The micropipette was then
switched to medium containing calcein AM and WGA conjugated to Alexa
Fluor 647 (ThermoFisher) and loading was imaged on a Nikon spinning
disk microscope. After 10 min, the micropipette was removed and cells were
incubated for 60 min in the microscope environmental chamber before a
4×4 field image was captured and stitched together using Nikon Elements
Software.
Single-particle-tracking photoactivation localization
microscopy
sptPALM experiments were conducted as described previously (Manley
et al., 2008). Briefly, MEFs were transfected with mEOS3–Cx43 and seeded
on fibronectin-coated #1.5 coverslips for TIRF microscopy. Cells were
imaged using a Nikon Ti3 TIRF system equipped with an Andor EMCCD
camera. mEOS3 molecules were photoconverted using a laser intensity,
pulse length and duration chosen to maintain a sparse population for
localization and tracking. Measurements were taken for seven MEFs each
transfected with mEOS3–Cx43. Molecules were localized using the
QuickPALM ImageJ plugin and tracks were assembled using MATLAB
(The Mathworks, Inc., Natick, MA). A linear fit of mean squared
displacements for 250 ms trajectories with at least 15 steps was used to
calculate the diffusion coefficient D for each condition.
Image processing
All images were processed using the ImageJ (NIH) FIJI build and compiled
in Adobe Illustrator. Live-cell images were converted into .avi movies using
ImageJ and converted into .mov files using Quicktime (Apple). Custom
ImageJ macro scripts were created to quantify GJ size, intensity and number
using threshold-defined regions of interest (ROIs). For myosin VI GJ line
profiles, 10 µm lines were drawn across all junctional structures (pointing
toward the center of the cell). Channel intensity was then calculated along
this line, saved and averaged with all other GJ plaques for the specified cell.
For micropipette calcein-loading experiments, lines were manually drawn
across the administration region and line plots were generated.
Presentation of data and statistics
All graphs were produced using GraphPad Prism software. Bar graphs
represent the mean plus the s.d. or s.e.m. as specified. Statistics were
calculated using the unpaired Student’s t-test.
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C., Kamińska, A. M. and Rędowicz, M. J. (2014). Myosin VI localization and
expression in striated muscle pathology. Anat. Rec. 297, 1706-1713.
Karolczak, J., Pavlyk, I., Majewski, Ł., Sobczak, M., Niewiadomski, P.,
Rzhepetskyy, Y., Sikorska, A., Nowak, N., Pomorski, P., Prószyński, T.
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